Vivos Therapeutics (VVOS) Depreciation & Amortization - Total (2020 - 2026)

Vivos Therapeutics (VVOS) has reported Depreciation & Amortization - Total for 7 consecutive years, with $300000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Depreciation & Amortization - Total changed 0.0% year-over-year to $300000.0 in Q2 2026; TTM through Jun 2026 was $800000.0, a 14.29% increase from a year earlier, with the FY2025 full-year figure at $700000.0, up 40.0% from the prior year.
• Depreciation & Amortization - Total was $300000.0 for Q2 2026 at Vivos Therapeutics, roughly flat from $300000.0 in the prior quarter.
• Over five years, Depreciation & Amortization - Total peaked at $400000.0 in Q3 2025 and troughed at -$200000.0 in Q4 2025.
• A 5-year average of $177777.8 and a median of $200000.0 in 2022 frame the typical range for Depreciation & Amortization - Total.
• The widest YoY moves for Depreciation & Amortization - Total: up 300.0% in 2025, down 300.0% in 2025.
• Over 5 years, Depreciation & Amortization - Total stood at $300000.0 in 2022, then plunged by 33.33% to $200000.0 in 2023, then slumped by 50.0% to $100000.0 in 2024, then slumped by 300.0% to -$200000.0 in 2025, then surged by 250.0% to $300000.0 in 2026.
• The last three Depreciation & Amortization - Total figures came in at $300000.0 (Q2 2026), $300000.0 (Q1 2026), and -$200000.0 (Q4 2025), per Business Quant data.